Showing results (1651-1660 of 3,793) with videos related to
Sort By:
Pageof 380
Oncoimmunology|May 4, 2016
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyKristina Iribarren, Norma Bloy, Aitziber Buqué, et al.Oncoimmunology|May 4, 2016
Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAFV600E melanomaShin Foong Ngiow, Katrina M Meeth, Kimberley Stannard, et al.Oncoimmunology|May 4, 2016
Small cell lung cancer: Recruitment of macrophages by circulating tumor cellsGerhard Hamilton, Barbara Rath, Lukas Klameth, et al.Oncoimmunology|May 4, 2016
Commentary: IL-12-secreting tumor-targeted chimeric antigen receptor T cells: An unaddressed concern on Koneru et al. (2015)Hamid Reza Mirzaei, Jamshid HadjatiOncoimmunology|May 4, 2016
Targeting immunosuppression by Tregs with monoclonal antibodies against GARPStéphanie Liénart, Julie Stockis, Olivier Dedobbeleer, et al.Oncoimmunology|May 4, 2016
NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitorsGuranda Chitadze, Marcus Lettau, Stefanie Luecke, et al.Oncoimmunology|May 4, 2016
Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasmsWojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, et al.Oncoimmunology|May 4, 2016
Attenuated Toxoplasma gondii therapy of disseminated pancreatic cancer generates long-lasting immunity to pancreatic cancerKiah L Sanders, Barbara A Fox, David J BzikOncoimmunology|May 4, 2016
Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survivalSabrina Genßler, Michael C Burger, Congcong Zhang, et al.Oncoimmunology|May 4, 2016
Metabolic tug-of-war in tumors results in diminished T cell antitumor immunityWan-Chen Cheng, Ping-Chih HoPageof 380